I think that AFI is a noteholder ? (Gameson, please confirm as I am not aware of them) so that means more dilution in the future (probably 1 year from now) unless they pay them cash. I think Cardio wants to get away from current noteholders for better deal.

If financing deal gets completed in mid October , the resumption of clinical trial would probably take 8-12 months. I doubt by end of December.

If financing is not announced by Oct 22, then the next release of shares to noteholder will surely put pressure on SP.